Top 5 Low Price Stocks To Own Right Now

Peyto (OTCPK:PEYUF) is a Canadian E&P company whose production profile is dominated by dry gas (92%). With the low price of natural gas, it has been a tough couple of years for Peyto’s shareholders. That said, the company has maintained its dividend payout through the commodity price downturn. Recently natural gas prices have recovered from their lows, but Peyto’s stock has not kept pace. In fact, it’s gone the other direction:

Click to enlarge

As the chart above show, the stock is down ~13% over the past three months as natural gas – as measure by both the Henry Hub and AECO indexes – has rallied sharply with significant winter withdrawals and forecasts that additional cold weather is on the way:

Top 5 Low Price Stocks To Own Right Now: Ascent Capital Group, Inc.(ASCMA)

Advisors’ Opinion:

  • [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

    Both of these stocks are overlooked, undervalued, and cash flow machines. The companies are Ascent Capital Group (ASCMA) and Covanta Holdings (CVA).

  • [By Lisa Levin]

    Tuesday afternoon, the industrial sector proved to be a source of strength for the market. Leading the sector was strength from NL Industries Inc (NYSE: NL) and Ascent Capital Group Inc (NASDAQ: ASCMA).

Top 5 Low Price Stocks To Own Right Now: Roper Technologies, Inc.(ROP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Aside from Outperform-rated Roper Technologies (ROP) SaaS platforms, which account for over +50% of earnings today, GEs Digital business strategy is the most ambitious ramp within the industrials sector. GE has made a bold bet on its game-changing Predix operating system for the Industrial IoT, which was launched in Feb-2016

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Monica Gerson]

    Analysts are expecting Roper Technologies Inc (NYSE: ROP) to have earned $1.46 per share on revenue of $895.87 million in the latest quarter. Roper Technologies shares declined 0.05 percent to close at $178.63 on Friday.

  • [By Monica Gerson]

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

    Express Scripts Holding Company (NASDAQ: ESRX) is expected to post its quarterly earnings at $1.22 per share on revenue of $25.20 billion.

Top 5 Low Price Stocks To Own Right Now: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Top 5 Low Price Stocks To Own Right Now: FORM Holdings (FH)

Advisors’ Opinion:

  • [By Matthew Briar]

    Looking for a quick, money-making trading idea? Put FORM Holdings Corp. (NASDAQ:FH) on your watchlist, if not yet in your portfolio. FH shares are knocking on the door of a breakout move, and one more nudge could do the trick.

    There are a couple of factors in play here. One of the is the converging wedge pattern that’s developed after the October-December finally stabilized. The upper boundary of that wedge at $2.40 has been tested several times since late last year, but FORM Holdings could never get past the hurdle. At the same time, several key moving average lines seem to be acting as support — even if unevenly — keeping FH positioned well for a breakout effort.

Top 5 Low Price Stocks To Own Right Now: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

Leave a Reply

Your email address will not be published. Required fields are marked *